Replies to post #724 on Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

I think RXII will get picked up for a partnership and I think it will have to do with either Wet AMD or Dry AMD.(macular degeneration).

1. For starters Macular degeneration is a $2 to $3 billion dollar market. Easy to find a partner when they see big money in it.

2. Second the technology works after seeing phase 1a single dose. I'm sure phase 1b multi dose results will be even better.